Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke

Journal of Physiology

Volumn 589, Issue 17, 2011, Pages 4125-4136

  Alfieri, Alessio ^a   Srivastava, Salil ^a   Siow, Richard C M ^a   Modo, Michel ^b   Fraser, Paul A ^a   Mann, Giovanni E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARNOSIC ACID; CASEIN KINASE II; CATALASE; CURCUMIN; EPICATECHIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEURITE OUTGROWTH PROMOTING PROSTAGLANDIN 11; PEROXIREDOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLUMBAGIN; PROTEIN KINASE C; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); STRESS ACTIVATED PROTEIN KINASE; SULFORAPHANE; SUPEROXIDE DISMUTASE; TERT BUTYLHYDROQUINONE; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL DEATH; CELL PROTECTION; CEREBROVASCULAR DISEASE; COMMON CAROTID ARTERY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STROKE; TRANSCRIPTION REGULATION; UBIQUITINATION; UPREGULATION; CEREBROVASCULAR ACCIDENT; METABOLISM;

ANTIOXIDANTS; BLOOD-BRAIN BARRIER; HUMANS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; STROKE;

EID: 80052256102     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.210294     Document Type: Review

References (85)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR & Begley DJ (2010). Structure and function of the blood-brain barrier. Neurobiol Dis 37, 13-25.
2. Abbott NJ, Ronnback L & Hansson E (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7, 41-53.
3. Adibhatla RM & Hatcher JF (2010). Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12, 125-169.
4. Allen CL & Bayraktutan U (2009). Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4, 461-470.
5. Arai K & Lo EH (2009). An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J Neurosci 29, 4351-4355.
6. Attwell D, Buchan AM, Charpak S, Lauritzen M, MacVicar BA & Newman EA (2010). Glial and neuronal control of brain blood flow. Nature 468, 232-243.
7. Balami JS, Chen RL, Grunwald IQ & Buchan AM (2011). Neurological complications of acute ischaemic stroke. Lancet Neurol 10, 357-371.
8. Baron JC (2001). Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 11 (Suppl. 1), 2-8.
9. Burdette D, Olivarez M & Waris G (2010). Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. J Gen Virol 91, 681-690.
10. Candelario-Jalil E (2009). Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs 10, 644-654.
11. Carmichael ST (2005). Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2, 396-409.
12. Chen RL, Balami JS, Esiri MM, Chen LK & Buchan AM (2010). Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol 6, 256-265.
13. Cheng X, Siow RC & Mann GE (2011). Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid Redox Signal 14, 469-487.
14. Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, Yin F, Boyadjian R, Bikineyeva A, Pratico D, Harrison DG & Hsueh WA (2009). Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res 104, e42-e54.
15. Crack PJ & Taylor JM (2005). Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38, 1433-1444.
16. Cuadrado A, Moreno-Murciano P & Pedraza-Chaverri J (2009). The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease. Expert Opin Ther Targets 13, 319-329.
17. del Zoppo GJ (2010). The neurovascular unit in the setting of stroke. J Intern Med 267, 156-171.
18. Demirovic D & Rattan SI (2011). Curcumin induces stress response and hormetically modulates wound healing ability of human skin fibroblasts undergoing ageing in vitro. Biogerontology; DOI:.
19. Dirnagl U, Simon RP & Hallenbeck JM (2003). Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26, 248-254.
20. Donnan GA, Fisher M, Macleod M & Davis SM (2008). Stroke. Lancet 371, 1612-1623.
21. Duan W, Zhang R, Guo Y, Jiang Y, Huang Y, Jiang H & Li C (2009). Nrf2 activity is lost in the spinal cord and its astrocytes of aged mice. In Vitro Cell Dev Biol Anim 45, 388-397.
22. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, Planas A, Rothwell N, Schwaninger M, Schwab ME, Vivien D, Wieloch T & Dirnagl U (2008). Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 25, 268-278.
23. Faraci FM (2005). Oxidative stress: the curse that underlies cerebral vascular dysfunction? Stroke 36, 186-188.
24. Guo S, Kim WJ, Lok J, Lee SR, Besancon E, Luo BH, Stins MF, Wang X, Dedhar S & Lo EH (2008). Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc Natl Acad Sci U S A 105, 7582-7587.
25. Gursoy-Ozdemir Y, Can A & Dalkara T (2004). Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35, 1449-1453.
26. Halliwell B (2001). Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18, 685-716.
27. Halliwell B (2006). Oxidative stress and neurodegeneration: where are we now? J Neurochem 97, 1634-1658.
28. Halliwell B (2011). Free radicals and antioxidants -quo vadis? Trends Pharmacol Sci 32, 125-130.
29. Huang HC, Nguyen T & Pickett CB (2000). Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci U S A 97, 12475-12480.
30. Iadecola C (2004). Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5, 347-360.
31. Innamorato NG, Rojo AI, Garcia-Yague AJ, Yamamoto M, De Ceballos ML & Cuadrado A (2008). The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 181, 680-689.
32. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M & Mann GE (2004). Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94, 609-616.
33. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S & Yamamoto M (2000). Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275, 16023-16029.
34. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD & Yamamoto M (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13, 76-86.
35. Jain AK & Jaiswal AK (2007). GSK-3β acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 282, 16502-16510.
36. Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, Song YS, Niizuma K, Katsu M, Okami N, Yoshioka H, Sakata H, Goeders CE & Chan PH (2010). Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 41, 172-179.
37. +-dependent GSH transport in HCEC. Brain Res 852, 374-382.
38. Kanninen K, Malm TM, Jyrkkanen HK, Goldsteins G, Keksa-Goldsteine V, Tanila H, Yamamoto M, Yla-Herttuala S, Levonen AL & Koistinaho J (2008). Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci 39, 302-313.
39. Kaspar JW, Niture SK & Jaiswal AK (2009). Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47, 1304-1309.
40. Kensler TW, Wakabayashi N & Biswal S (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47, 89-116.
41. Lakhan SE, Kirchgessner A & Hofer M (2009). Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7, 97.
42. Lee BJ, Egi Y, van Leyen K, Lo EH & Arai K (2010). Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro. Brain Res 1307, 22-27.
43. Lee JM, Shih AY, Murphy TH & Johnson JA (2003). NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J Biol Chem 278, 37948-37956.
44. Liverman CS, Cui L, Yong C, Choudhuri R, Klein RM, Welch KM & Berman NE (2004). Response of the brain to oligemia: gene expression, c-Fos, and Nrf2 localization. Brain Res Mol Brain Res 126, 57-66.
45. McMahon M, Itoh K, Yamamoto M & Hayes JD (2003). Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 278, 21592-21600.
46. McWalter GK, Higgins LG, McLellan LI, Henderson CJ, Song L, Thornalley PJ, Itoh K, Yamamoto M & Hayes JD (2004). Transcription factor Nrf2 is essential for induction of NAD(P)H:quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates. J Nutr 134, 3499S-3506S.
47. Mann GE, Bonacasa B, Ishii T & Siow RC (2009). Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones. Curr Opin Pharmacol 9, 139-145.
48. Marklund SL, Westman NG, Lundgren E & Roos G (1982). Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res 42, 1955-1961.
49. Moi P, Chan K, Asunis I, Cao A & Kan YW (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the β-globin locus control region. Proc Natl Acad Sci U S A 91, 9926-9930.
50. Moskowitz MA, Lo EH & Iadecola C (2010). The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198.
51. Motohashi H & Yamamoto M (2004). Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10, 549-557.
52. Nagayama T, Lan J, Henshall DC, Chen D, O'Horo C, Simon RP & Chen J (2000). Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J Neurochem 75, 1716-1728.
53. Negi G, Kumar A & Sharma SS (2011). Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades. J Pineal Res 50, 124-131.
54. Niizuma K, Endo H & Chan PH (2009). Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 109 (Suppl. 1), 133-138.
55. Rice ME (2000). Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 23, 209-216.
56. Rizzo MT & Leaver HA (2010). Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and disease. Mol Neurobiol 42, 52-63.
57. Rojo AI, Innamorato NG, Martin-Moreno AM, De Ceballos ML, Yamamoto M & Cuadrado A (2010). Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 58, 588-598.
58. Rushmore TH & Kong AN (2002). Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 3, 481-490.
59. Satoh T, Baba M, Nakatsuka D, Ishikawa Y, Aburatani H, Furuta K, Ishikawa T, Hatanaka H, Suzuki M & Watanabe Y (2003). Role of heme oxygenase-1 protein in the neuroprotective effects of cyclopentenone prostaglandin derivatives under oxidative stress. Eur J Neurosci 17, 2249-2255.
60. Satoh T, Kosaka K, Itoh K, Kobayashi A, Yamamoto M, Shimojo Y, Kitajima C, Cui J, Kamins J, Okamoto S, Izumi M, Shirasawa T & Lipton SA (2008). Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem 104, 1116-1131.
61. Satoh T, Okamoto SI, Cui J, Watanabe Y, Furuta K, Suzuki M, Tohyama K & Lipton SA (2006). Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. Proc Natl Acad Sci U S A 103, 768-773.
62. Schroeter ML, Mertsch K, Giese H, Muller S, Sporbert A, Hickel B & Blasig IE (1999). Astrocytes enhance radical defence in capillary endothelial cells constituting the blood-brain barrier. FEBS Lett 449, 241-244.
63. Shah ZA, Li RC, Ahmad AS, Kensler TW, Yamamoto M, Biswal S & Dore S (2010). The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. J Cereb Blood Flow Metab 30, 1951-1961.
64. Shah ZA, Li RC, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S & Dore S (2007). Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuroscience 147, 53-59.
65. Shih AY, Li P & Murphy TH (2005). A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci 25, 10321-10335.
66. Simpson JE, Ince PG, Haynes LJ, Theaker R, Gelsthorpe C, Baxter L, Forster G, Lace GL, Shaw PJ, Matthews FE, Savva GM, Brayne C & Wharton SB (2010). Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the ageing brain. Neuropathol Appl Neurobiol 36, 25-40.
67. Siow RC & Mann GE (2010). Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis? Mol Aspects Med 31, 468-477.
68. Son TG, Camandola S, Arumugam TV, Cutler RG, Telljohann RS, Mughal MR, Moore TA, Luo W, Yu QS, Johnson DA, Johnson JA, Greig NH & Mattson MP (2010). Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia. J Neurochem 112, 1316-1326.
69. Stack C, Ho D, Wille E, Calingasan NY, Williams C, Liby K, Sporn M, Dumont M & Beal MF (2010). Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. Free Radic Biol Med 49, 147-158.
70. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM & Hagen TM (2004). Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 101, 3381-3386.
71. Sukumari-Ramesh S, Laird MD, Singh N, Vender JR, Alleyne CH, Jr & Dhandapani KM (2010). Astrocyte-derived glutathione attenuates hemin-induced apoptosis in cerebral microvascular cells. Glia 58, 1858-1870.
72. Surh YJ, Kundu JK & Na HK (2008). Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 74, 1526-1539.
73. Swanson RA, Ying W & Kauppinen TM (2004). Astrocyte influences on ischemic neuronal death. Curr Mol Med 4, 193-205.
74. Tanaka N, Ikeda Y, Ohta Y, Deguchi K, Tian F, Shang J, Matsuura T & Abe K (2011). Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion. Brain Res 1370, 246-253.
75. Tong KI, Padmanabhan B, Kobayashi A, Shang C, Hirotsu Y, Yokoyama S & Yamamoto M (2007). Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol Cell Biol 27, 7511-7521.
76. Vargas MR & Johnson JA (2009). The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med 11, e17.
77. Wakabayashi N, Slocum SL, Skoko JJ, Shin S & Kensler TW (2010). When NRF2 talks, who's listening? Antioxid Redox Signal 13, 1649-1663.
78. Wilson JX (2002). The physiological role of dehydroascorbic acid. FEBS Lett 527, 5-9.
79. Yan W, Wang HD, Hu ZG, Wang QF & Yin HX (2008). Activation of Nrf2-ARE pathway in brain after traumatic brain injury. Neurosci Lett 431, 150-154.
80. Yang C, Zhang X, Fan H & Liu Y (2009). Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 1282, 133-141.
81. Yuan J (2009). Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis 14, 469-477.
82. Zaleska MM & Floyd RA (1985). Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron. Neurochem Res 10, 397-410.
83. Zhao J, Kobori N, Aronowski J & Dash PK (2006). Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett 393, 108-112.
84. Zhao J, Moore AN, Redell JB & Dash PK (2007). Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci 27, 10240-10248.
85. Zhao XD, Zhou YT, Zhang X, Wang XL, Qi W, Zhuang Z, Su XF & Shi JX (2010). Expression of NF-E2-related factor 2 (Nrf2) in the basilar artery after experimental subarachnoid hemorrhage in rabbits: a preliminary study. Brain Res 1358, 221-227.